vs
Jerash Holdings (US), Inc.(JRSH)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Jerash Holdings (US), Inc.的1.7倍($69.8M vs $41.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs 2.8%,领先381.2%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs 18.0%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 39.1%)
Jerash Holdings (US), Inc. 是一家全球化服装制造商,为国际知名零售及服饰品牌生产高品质外套、运动服、休闲装及功能性服饰,核心市场覆盖北美、欧洲及亚太地区,在约旦及东南亚设有生产基地。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
JRSH vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.7倍
$41.8M
营收增速更快
RIGL
高出3.1%
18.0%
净利率更高
RIGL
高出381.2%
2.8%
两年增速更快
RIGL
近两年复合增速
39.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $41.8M | $69.8M |
| 净利润 | $1.2M | $268.1M |
| 毛利率 | 16.9% | 91.5% |
| 营业利润率 | 4.7% | 33.2% |
| 净利率 | 2.8% | 384.0% |
| 营收同比 | 18.0% | 21.2% |
| 净利润同比 | 20261.5% | 1769.2% |
| 每股收益(稀释后) | $0.09 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
JRSH
RIGL
| Q4 25 | $41.8M | $69.8M | ||
| Q3 25 | $42.0M | $69.5M | ||
| Q2 25 | $39.6M | $101.7M | ||
| Q1 25 | $29.3M | $53.3M | ||
| Q4 24 | $35.4M | $57.6M | ||
| Q3 24 | $40.2M | $55.3M | ||
| Q2 24 | $40.9M | $36.8M | ||
| Q1 24 | $21.6M | $29.5M |
净利润
JRSH
RIGL
| Q4 25 | $1.2M | $268.1M | ||
| Q3 25 | $461.6K | $27.9M | ||
| Q2 25 | $318.7K | $59.6M | ||
| Q1 25 | $-152.6K | $11.4M | ||
| Q4 24 | $-5.8K | $14.3M | ||
| Q3 24 | $655.3K | $12.4M | ||
| Q2 24 | $-1.3M | $-1.0M | ||
| Q1 24 | $-3.1M | $-8.2M |
毛利率
JRSH
RIGL
| Q4 25 | 16.9% | 91.5% | ||
| Q3 25 | 15.0% | 93.2% | ||
| Q2 25 | 15.4% | 95.6% | ||
| Q1 25 | 17.9% | 91.7% | ||
| Q4 24 | 15.2% | 89.9% | ||
| Q3 24 | 17.5% | 85.5% | ||
| Q2 24 | 11.3% | 92.4% | ||
| Q1 24 | 7.0% | 93.1% |
营业利润率
JRSH
RIGL
| Q4 25 | 4.7% | 33.2% | ||
| Q3 25 | 2.6% | 40.9% | ||
| Q2 25 | 2.4% | 60.1% | ||
| Q1 25 | 1.5% | 23.9% | ||
| Q4 24 | 2.0% | 28.9% | ||
| Q3 24 | 2.8% | 25.4% | ||
| Q2 24 | -2.0% | 1.2% | ||
| Q1 24 | -14.0% | -23.6% |
净利率
JRSH
RIGL
| Q4 25 | 2.8% | 384.0% | ||
| Q3 25 | 1.1% | 40.2% | ||
| Q2 25 | 0.8% | 58.6% | ||
| Q1 25 | -0.5% | 21.5% | ||
| Q4 24 | -0.0% | 24.9% | ||
| Q3 24 | 1.6% | 22.5% | ||
| Q2 24 | -3.3% | -2.8% | ||
| Q1 24 | -14.3% | -27.9% |
每股收益(稀释后)
JRSH
RIGL
| Q4 25 | $0.09 | $14.11 | ||
| Q3 25 | $0.04 | $1.46 | ||
| Q2 25 | $0.03 | $3.28 | ||
| Q1 25 | $-0.01 | $0.63 | ||
| Q4 24 | $0.00 | $0.82 | ||
| Q3 24 | $0.05 | $0.70 | ||
| Q2 24 | $-0.11 | $-0.06 | ||
| Q1 24 | $-0.25 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $11.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $63.6M | $391.5M |
| 总资产 | $84.2M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
JRSH
RIGL
| Q4 25 | $11.5M | $155.0M | ||
| Q3 25 | $12.0M | $137.1M | ||
| Q2 25 | $5.8M | $108.4M | ||
| Q1 25 | $13.3M | $77.1M | ||
| Q4 24 | $13.2M | $77.3M | ||
| Q3 24 | $16.3M | $61.1M | ||
| Q2 24 | $11.4M | $49.1M | ||
| Q1 24 | $12.4M | $49.5M |
总债务
JRSH
RIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益
JRSH
RIGL
| Q4 25 | $63.6M | $391.5M | ||
| Q3 25 | $62.8M | $117.6M | ||
| Q2 25 | $62.7M | $81.9M | ||
| Q1 25 | $62.8M | $18.6M | ||
| Q4 24 | $63.1M | $3.3M | ||
| Q3 24 | $63.4M | $-14.6M | ||
| Q2 24 | $62.9M | $-29.9M | ||
| Q1 24 | $64.4M | $-31.7M |
总资产
JRSH
RIGL
| Q4 25 | $84.2M | $513.6M | ||
| Q3 25 | $83.3M | $242.5M | ||
| Q2 25 | $81.7M | $206.7M | ||
| Q1 25 | $83.0M | $176.0M | ||
| Q4 24 | $79.8M | $164.0M | ||
| Q3 24 | $80.3M | $139.4M | ||
| Q2 24 | $76.7M | $128.4M | ||
| Q1 24 | $80.2M | $126.5M |
负债/权益比
JRSH
RIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-3.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-3.9M | — |
| 自由现金流率自由现金流/营收 | -9.3% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | -3.25× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-2.9M | — |
8季度趋势,按日历期对齐
经营现金流
JRSH
RIGL
| Q4 25 | $-3.8M | $22.0M | ||
| Q3 25 | $6.8M | $24.0M | ||
| Q2 25 | $-6.5M | $30.5M | ||
| Q1 25 | $1.9M | $-893.0K | ||
| Q4 24 | $-3.0M | $14.5M | ||
| Q3 24 | $4.6M | $21.7M | ||
| Q2 24 | $-2.2M | $302.0K | ||
| Q1 24 | $-5.4M | $-5.0M |
自由现金流
JRSH
RIGL
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $6.4M | — | ||
| Q2 25 | $-6.9M | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $4.4M | — | ||
| Q2 24 | $-2.3M | — | ||
| Q1 24 | $-5.8M | — |
自由现金流率
JRSH
RIGL
| Q4 25 | -9.3% | — | ||
| Q3 25 | 15.3% | — | ||
| Q2 25 | -17.5% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | -8.9% | — | ||
| Q3 24 | 11.0% | — | ||
| Q2 24 | -5.7% | — | ||
| Q1 24 | -26.9% | — |
资本支出强度
JRSH
RIGL
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.9% | — |
现金转化率
JRSH
RIGL
| Q4 25 | -3.25× | 0.08× | ||
| Q3 25 | 14.72× | 0.86× | ||
| Q2 25 | -20.33× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 7.06× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图